Healthcare -
Biotechnology - NASDAQ - US
$ 11.535
-1.49 %
$ 467 M
Market Cap
-2.21
P/E
KROS - TOTAL EQUITY
Total Equity KROS - Keros Therapeutics, Inc.
332 M
LAST VALUE
16.88%
2 YEAR CAGR
91.92%
5 YEAR CAGR
0.00%
10 YEAR CAGR